Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMN 110 in Pediatric MPS IVA (< 5 Years)
NCT01515956Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Oct 2011
- Primary completion
- Feb 2016
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of elosulfase alfa in Mucopolysaccharidosis type IV A, sponsored by BioMarin Pharmaceutical. Started Oct 2011; status: completed.
02
Drugs
elosulfase alfa
03
Conditions
Mucopolysaccharidosis type IV A
Beyond the preview
Go deeper on NCT01515956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515956.